CSIQ · Canadian Solar Inc.

Current Thesis

Canadian Solar’s remaining recovery thesis is domestic-module contract repricing, which requires documented price increases and a recovery above the former $14.00 market shelf before a weekly close below $12.00 invalidates it. On the 2026-08-27 earnings call, management described more than $4.5 billion of contracted domestic-module revenue through 2029 whose value excluded adjustments under the new Section 232 policy. That is management’s proposed earnings mechanism; completed repricing was not established on that call. Earnings-call transcript

The inference is that the narrative is maturing — the policy mechanism was already discussed on 2026-08-27, while the 2026-09-11 adjusted close of $12.76 remained below the former $14.00 shelf. Since the previous publication, Wells Fargo’s 2026-08-31 reduction of its analyst target to $17 extended the downward estimate reassessment. The company’s news index, checked on 2026-09-13, still lists the 2026-08-27 results as its latest release. Analyst-action record, Company releases

Bullish and bearish views on Canadian Solar Inc.

The model's bull view on Canadian Solar Inc. (CSIQ), in brief: Contracts contain repricing mechanisms. On 2026-08-27, management said domestic-module agreements contain change-in-law adjustments and that customer renegotiations were underway. The inference that policy can improve contracted economics fails if subsequent disclosures show… The bear view: Revenue guidance remains the constraint. Both cases follow in full.

Bull Case

• Contracts contain repricing mechanisms. On 2026-08-27, management said domestic-module agreements contain change-in-law adjustments and that customer renegotiations were underway. The inference that policy can improve contracted economics fails if subsequent disclosures show unchanged contractual pricing. Earnings-call transcript
• Storage exceeded shipment guidance. Second-quarter 2026 storage shipments reached 3.7 gigawatt-hours against guidance of 2.8–3.2 gigawatt-hours, according to the 2026-08-27 release. This is measured operating execution; it does not establish future shipment growth. Filed results
• Domestic production has a deadline. Management’s 2026-08-27 call scheduled Jeffersonville Phase I full-scale production for 2026-10-01. That manufacturing milestone fails if the company reports a delay beyond the stated date. Earnings-call transcript

Bear Case

• Revenue guidance remains the constraint. The 2026-08-27 release guided third-quarter 2026 revenue to $1.3–1.5 billion. Revenue at or below $1.3 billion would defeat the proposed operating recovery under this thesis. Filed results
• Factory costs persist through year-end. In the 2026-08-27 release, management explicitly expected Jeffersonville ramp-up costs to weigh on profitability for the remainder of 2026. Domestic production therefore does not establish an immediate margin improvement. Filed results
• Analyst support was revised downward. Wells Fargo maintained Equal-Weight and reduced its analyst target to $17 on 2026-08-31. The revision documents weaker analyst expectations, not a measured change in investor holdings. Analyst-action record

Setup & Price Structure

The supplied adjusted market record puts the 2026-09-11 close at $12.76, with a three-month price decline of 23.7% and a 62.0% distance below the adjusted 52-week high. The 14-period relative strength index was 34.3 on that date. These observations establish weak price momentum; they do not establish a completed base.

The former $14.00 shelf identified in the 2026-08-30 public note remains the recovery reference, while $12.00 remains the published thesis-break threshold. A weekly close above $14.00 would satisfy the price component of the recovery case; a weekly close below $12.00 would invalidate it. The supplied record does not establish whether that lower threshold was breached on an intervening weekly close.

Positioning evidence is insufficient: the dated analyst revision is observable, but the available record contains no current short-interest figure, ownership-flow series, retail-attention series or moving-average measurement. It supports no crowding conclusion.

Catalyst Calendar (next 30 days)

• 2026-10-01 — Jeffersonville production milestone. The 2026-08-27 call scheduled Phase I full-scale production for this date. This is a management operating deadline, not a separately announced results event; a reported delay would contradict the schedule. Earnings-call transcript
• 2026-12-04 — Policy implementation beyond the window. The 2026-08-06 Section 232 proclamation provides the later implementation date on which the contract-repricing thesis turns. Implementation alone would not demonstrate that Canadian Solar secured higher contract prices. Presidential proclamation

What Would Change Our Mind

Failure to establish support above the published downside threshold would end the price-recovery case: a weekly close below $12.00 is the observable invalidation. Fundamental invalidation would also occur if third-quarter 2026 revenue lands at or below the $1.3 billion lower bound of management’s 2026-08-27 guidance.

The positive case requires disclosed domestic-module contract price increases alongside a weekly close above the former $14.00 shelf. A higher aggregate backlog alone would be insufficient because additional orders could increase its value without repricing existing contracts.

Correlation Notes

This is a single-company manufacturing and contract-execution thesis. The 2026-08-27 release identifies both module manufacturing and battery-storage shipments, but the available record supplies no matched peer-return series from which to establish market correlation. A broader solar-sector recovery is therefore not an evidenced component of the case. Filed results